
### [NCIT:C3584](http://purl.obolibrary.org/obo/NCIT_C3584)
**Label:** Stage III Hodgkin Lymphoma

**Subclasses:** [NCIT:C3583](http://purl.obolibrary.org/obo/NCIT_C3583) (Stage III Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C7262](http://purl.obolibrary.org/obo/NCIT_C7262) (Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma), [NCIT:C8057](http://purl.obolibrary.org/obo/NCIT_C8057) (Stage III Childhood Hodgkin Lymphoma), [NCIT:C3582](http://purl.obolibrary.org/obo/NCIT_C3582) (Stage III Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C9034](http://purl.obolibrary.org/obo/NCIT_C9034) (Stage III Adult Hodgkin Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C27970](http://purl.obolibrary.org/obo/NCIT_C27970) (Stage III) 54.17%
- Thing 52.77%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39253](http://purl.obolibrary.org/obo/NCIT_C39253) (Interferon Signaling Modulation Pathway))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39250](http://purl.obolibrary.org/obo/NCIT_C39250) (Mucosal Healing Pathway))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39247](http://purl.obolibrary.org/obo/NCIT_C39247) (Telomere Pathway))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39246](http://purl.obolibrary.org/obo/NCIT_C39246) (T Cell Receptor Signaling Pathway BioCarta))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39236](http://purl.obolibrary.org/obo/NCIT_C39236) (Sprouty Regulation of Tyrosine Kinase Signaling Pathway))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39217](http://purl.obolibrary.org/obo/NCIT_C39217) (Ras Signaling Pathway))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39208](http://purl.obolibrary.org/obo/NCIT_C39208) (Rac1 Cell Motility Signaling Pathway))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39197](http://purl.obolibrary.org/obo/NCIT_C39197) (PPAR-alpha Gene Regulation Pathway))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39194](http://purl.obolibrary.org/obo/NCIT_C39194) (Phospholipase C Signaling Pathway))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39184](http://purl.obolibrary.org/obo/NCIT_C39184) (PDGF Signaling Pathway))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39168](http://purl.obolibrary.org/obo/NCIT_C39168) (NO2-Dependent IL12 Pathway))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39167](http://purl.obolibrary.org/obo/NCIT_C39167) (Nitric Oxide Pathway))) 39.52%


